期刊文献+

无细胞百日咳疫苗生产用培养基的改进和培养条件优化 被引量:2

Improvement of Culture Medium for Production of Acellular Pertussis Vaccine and Optimization of Its Culture Conditions
下载PDF
导出
摘要 目的:改进无细胞百日咳疫苗生产用培养基并优化培养条件。方法:用不同浓度溶血(0. 1%)赫氏琼脂及酸水解酪蛋白制备百日咳活性炭培养基,选择最优培养条件;使用百日咳活性炭培养基成功复苏菌种后,优化传代代次和培养时间,评价百日咳活性炭培养基替代羊血包姜氏培养基的可行性;用酸水解酪蛋白代替自制50%酸水解酪蛋白制备改良SS液体培养基,并用ELISA、SDS-PAGE电泳和CHO细胞簇集等方法评价对菌种的培养效果。结果:溶血(0. 1%)赫氏琼脂的加入量为33. 2g/L、酸水解酪蛋白加入量为8g/L时,菌苔生长最快;百日咳活性炭培养基培养第1代72 h、第2代48 h、第3代48 h、第4代24 h和第1代72 h、第2代36 h、第3代24 h的血凝(HA)和UV600均较高,这两组细菌生长状态较好;酸水解酪蛋白制备的百日咳活性炭培养基在优化条件后复苏菌种生长良好,和羊血包姜氏培养基没有明显差异; 8g/L酸水解酪蛋白制备的改良SS液体培养基所得菌量优于50%酸水解酪蛋白制备培养基(P=0. 001),改良SS液体培养基培养所得百日咳毒素纯度、产量和CHO细胞簇集活性均较好。结论:使用酸水解酪蛋白的百日咳活性炭培养基和改良SS液体培养基所得的百日咳杆菌纯度、产量、活性均较高,适用于无细胞百日咳组分疫苗的生产。 Objective: To improve the culture medium for acellular pertussis vaccine production and optimize its culture conditions. Methods: Hottinger's Agar of different concentrations and acid hydrolyzed casein were used to prepare pertussis activated carbon medium with optimal culture conditions. After resuscitating the strains with pertussis activated carbon medium, passage and culture time wure optimized and the feasibility of replacing pertussis activated carbon medium with sheep blood-stained medium was evaluated. Acid hydrolyzed casein was used to replace 50% acid hydrolyzed casein in modified SS liquid medium, and the culture effects of the strain were evaluated by ELISA, SDS-PAGE electrophuresis and CHO cell clustering. Results: When Hottingerg Agar was added in an amount of 33.2 g/L and acid hydrolyzed casein was added in an amount of 8 g/L, the lawn glow with the fastest speed. HA and UV600 of pertussis activated carbon medium were higher and bacteria glow better in two sub-cultures-the first generation 72 h, the second generation 48 h, the third generation 48 h, and the fourth generation 24 h and the first generation 72 h, the second generation 36 h, and the third gen- eration 24 h. The pertussis activated carbon medium prepured by acid hydrolysis of casein was well-developed after optimized conditions, and there was no significant difference between the blood and the culture medium of sheep blood. The number of bacteria in the modified SS liquid medium prepared by 8g/L acid hydrolysis casein was better than that of self-made 50% acid hydrolysis casein preparation medium (P = 0. 001 ) , and the purity, yield and bioactivity to CliO cells were good. Conclusion : The pertussis dried bacteria obtained by the pertussis activated carbon medium using acid hydrolyzed casein and the modified SS liquid medium have higher purity, yield and activity, and were suitable for the production of the acellular pertussis vaccine.
作者 梁疆莉 姬秋彦 罗娜 姬光 高娜 马艳 史荔 孙明波 衡燮 LIANG Jiangli;JI Qiuyan;LUO Na;JI Guang;GAO Na;MA Yan;SHI Li;SUN Mingbo;HENG Xie(Institute of Medical Biology,Chinese Academy of Medical Sciences & Peking Union Medical College,Kunming 650118,Yunnan,China)
出处 《贵州医科大学学报》 CAS 2018年第10期1232-1236,共5页 Journal of Guizhou Medical University
基金 国家科技重大专项课题基金资助项目(2015ZX09101031) 中国医学科学院重大协同创新资助项目"创新性疫苗研究"(2016-12M-1-019)
关键词 博德特菌 百日咳 百日咳毒素 培养基 仓鼠卵巢细胞 酶联免疫吸附测定 Bordetella pertussis pertussis toxin culture medium CHO cells enzyme-linked immunosorbent assay
  • 相关文献

参考文献1

二级参考文献7

  • 1国家药典委员会.中国药典(三部)[s].北京:中国医药科技出版社,2010:111-114.
  • 2Dalby T, Sorensen C, Petersen JW, et al. Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay [J]. APMIS, 2010, 118(12): 968-972.
  • 3Hewlett EL, Sauer KT, Myers GA, et al. Induction of a novel morphological response in Chinese hamster ovary cells by per- tussis toxin [J]. Infect Immun, 1983, 40(3): 1198-1203.
  • 4Sato H, Sato Y, ho A, et al. Effect of monoclonal antibody to pertussis toxin on toxin activity [J]. Infect Immun, 1987, 55(4): 909-915.
  • 5Thierry-Carstensen B, Dalby T, Stevner MA, et al. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and aduhs-a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience [J]. Vaccine, 2013, 31(45) : 5178-5191.
  • 6Wang L, Lei D, Zhang S. Acellular pertussis vaccines in China [J]. Vaccine, 2012, 30 (50): 7174-7178.
  • 7Gaines-Das R, Horiuchi Y, Zhang SM, et al. Modified intra- cerebral challenge assay for acellular pertussis vaccines: com- parisons among whole cell and aeellular vaccines [J]. Vaccine, 2009, 27 (49): 6824-6832.

共引文献7

同被引文献14

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部